Skip to content

Author

M. Kwan

We have 5 of 319 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Understanding competing mortality in patients with early-stage ER+ breast cancer.

217 Background: Long-term endocrine therapy reduces recurrence in early-stage hormone receptor-positive breast cancer (BC) but may worsen comorbidities and survival. Understanding competing causes of mortality is essential for individualized treatment. We characterized cause-specific mortality and risk factor p...

C. Wabl, Morah Brown, Shi-Yun Zhu et al. · 0 citations
Open access Sep 2026

Guideline-recommended post-operative intravesical chemotherapy and cystoscopic surveillance among patients with low- and intermediate-risk non-muscle invasive bladder cancer

Introduction We sought to characterize concordance of surveillance and treatment patterns in a large community-based healthcare system with the American Urologic Association/Society of Urologic Oncology (AUA/SUO) guideline for low- and intermediate-risk non-muscle invasive bladder cancer (NMIBC). We expect the results...

M. Shulman, V. Lee, J. Roh et al. · 0 citations
Open access Sep 2026

Endocrine therapy adherence and 10-year cardiometabolic risk in hormone receptor-positive breast cancer.

BACKGROUND Adjuvant endocrine therapy (AET) reduces breast cancer (BC) recurrence but may adversely affect cardiometabolic health. We evaluated the association between AET adherence duration and 10-year risk of hypertension, dyslipidemia, diabetes, and mortality among postmenopausal women with early-stage hormone recep...

J. R. Ledesma, Joshua R. Nugent, R. Cheng et al. · 0 citations
Review Open access Aug 2026

Self-reported racial and ethnic discrimination in patient-provider interactions and the initiation of adjuvant therapies for breast cancer in the pathways study

Self-reported racial/ethnic discrimination in patient-provider interactions was associated with the non-initiation of hormonal therapy in women with breast cancer and the impact of this association on breast cancer prognosis.

Kevin R Bitsie, Thomas A. Pearson, M. Kwan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.